To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
Within the Institute, the "Funding Research and Technology Transfer" team is at your disposal to identify the scientists and the skills you need to set up a joint project, to define the terms of a collaboration contract or study.
Whether you are an academic, a SME or an industrialist, our team informs and advices you about the possibilities of consortium assembly, technology transfer, patent licensing or use of our platforms.
The team is also at the disposal of the researchers of the institute to accompany them in achieving their valorization objectives.
All the news of the Institute of life sciences Frédéric Joliot
Diagnosis and innovative treatment
Research activity in the field of diagnostic and therapeutic innovation is carried out by the two departments of Medicines and Technologies for Health and NeuroSpin and the Service Hospitalier Frédéric Joliot (SHFJ). Based on complementary expertise among the Institute (organic chemistry, radiochemistry and associated imaging, molecular protein engineering, mass and omic spectrometry, immunoanalysis, biomedical imaging, clinical research), this research is based on two axes of innovation:
to reach the following objectives:
The main areas of application are: oncological diseases, cardiovascular diseases, neurological diseases, psychiatric diseases and infectious diseases.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.